Male Infertility Market Size

  • Report ID: 6485
  • Published Date: Sep 30, 2024
  • Report Format: PDF, PPT

Male Infertility Market Size

Male Infertility Market size is assessed at USD 4.4 billion in 2024 and is set to exceed USD 8.4 billion by the end of 2037, growing at over 4.8% CAGR during the forecast period i.e., between 2025-2037. In 2025, the industry size of male infertility is estimated at USD 4.6 billion.

The male infertility market is poised to witness significant growth owing to increased acceptance of male infertility as a medical condition. The shift in societal attitudes has led to a surge in demand for treatments, diagnostics tests, and support services. As the dissemination of information becomes easier due to rising digitization, more men and couples will become educated about male infertility, further boosting the male infertility market growth.

The World Health Organization (WHO) states low sperm count, abnormal morphology and motility of sperm, and issues in ejaculation are the most common issues for male infertility. Male infertility can be categorized into primary and secondary infertility i.e. primary infertility is when a male has never impregnated a fertile female and secondary infertility is when the male has impregnated a female prior but is unable to do so for the second term. As male infertility cases rise due to unhealthy diets, increasing stress levels, and sedentary lifestyles, the demand for specialized male fertility care is projected to boom.

An Oxford Academic paper estimated male infertility affects 7% of all men. The increased media coverage on news outlets and social media platforms has managed to dispel misconceptions about male infertility. Additionally, celebrity advocacy such as from Gordon Ramsay, Mark Zuckerberg, John Legend, etc., has led to greater penetration in dispelling stigmas associated with male infertility. The percentage of males undergoing fertility tests increases as fertility care improves globally which leads to the remarkable growth of the market revenue share.


Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 6485
  • Published Date: Sep 30, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

The male infertility market was valued at USD 4.4 billion in 2024 and is poised to register a profitable CAGR of 4.8% during the forecast period, i.e., 2025-2037.

The male infertility market was valued at USD 4.4 billion in 2024 and is estimated to reach USD 8.4 billion by 2037 at a CAGR of 4.8% during the forecast period, i.e., 2025-2037. In 2025, the global market is projected to reach USD 4.6 billion.

The major players in the market are Andrology Solutions, Merck, Vitrolife Group, HalotechDNA, Bayer AG, SCSA Diagnostics, Inc., Examen, Carrot Fertility, and others.

The hospital pharmacies segment is projected to capture the largest revenue share with a 31% market share by 2037.

North America is estimated to provide the largest revenue opportunities by 2037. The market in North America was estimated at USD 1.8 billion in 2024.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample